DAddario C, Di Bartolomeo M
Subcell Biochem. 2025; 108():191-215.
PMID: 39820863
DOI: 10.1007/978-3-031-75980-2_5.
Lorenc-Koci E, Gorny M, Chwatko G, Kaminska K, Iciek M, Rogoz Z
Pharmacol Rep. 2024; 76(4):863-877.
PMID: 38904712
PMC: 11294273.
DOI: 10.1007/s43440-024-00607-3.
Crunfli F, Brandao-Teles C, Zuccoli G, Chaves Filho A, Vieira G, Silva-Amaral D
Adv Exp Med Biol. 2022; 1400:15-33.
PMID: 35930223
DOI: 10.1007/978-3-030-97182-3_2.
Landreth K, Simanaviciute U, Fletcher J, Grayson B, Grant R, Harte M
Brain Neurosci Adv. 2022; 5:23982128211003199.
PMID: 35392130
PMC: 8981243.
DOI: 10.1177/23982128211003199.
Wang L, Ma T, Qiao D, Cui K, Bi X, Han C
BMC Psychiatry. 2022; 22(1):171.
PMID: 35260124
PMC: 8903623.
DOI: 10.1186/s12888-022-03799-1.
Psychopharmacology: From serendipitous discoveries to rationale design, but what next?.
Robinson E
Brain Neurosci Adv. 2020; 2:2398212818812629.
PMID: 32166162
PMC: 7058199.
DOI: 10.1177/2398212818812629.
Effect of pre- and post-treatment with (Brahmi) on phencyclidine-induced disruptions in object recognition memory and cerebral calbindin, parvalbumin, and calretinin immunoreactivity in rats.
Piyabhan P, Tingpej P, Duansak N
Neuropsychiatr Dis Treat. 2019; 15:1103-1117.
PMID: 31118643
PMC: 6503340.
DOI: 10.2147/NDT.S193222.
An Overview of Animal Models Related to Schizophrenia.
Winship I, Dursun S, Baker G, Balista P, Kandratavicius L, Maia-de-Oliveira J
Can J Psychiatry. 2018; 64(1):5-17.
PMID: 29742910
PMC: 6364139.
DOI: 10.1177/0706743718773728.
Profiles of VGF Peptides in the Rat Brain and Their Modulations after Phencyclidine Treatment.
Noli B, Sanna F, Brancia C, DAmato F, Manconi B, Vincenzoni F
Front Cell Neurosci. 2017; 11:158.
PMID: 28626390
PMC: 5454051.
DOI: 10.3389/fncel.2017.00158.
Effects of Repeated Ropinirole Treatment on Phencyclidine-Induced Hyperlocomotion, Prepulse Inhibition Deficits, and Social Avoidance in Rats.
Maple A, Call T, Kimmel P, Hammer Jr R
J Pharmacol Exp Ther. 2017; 361(1):109-114.
PMID: 28167638
PMC: 11047206.
DOI: 10.1124/jpet.116.238634.
Legal highs: staying on top of the flood of novel psychoactive substances.
Baumeister D, Tojo L, Tracy D
Ther Adv Psychopharmacol. 2015; 5(2):97-132.
PMID: 26240749
PMC: 4521440.
DOI: 10.1177/2045125314559539.
Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.
Cheng J, Xiong Z, Duffney L, Wei J, Liu A, Liu S
Biol Psychiatry. 2014; 76(12):953-62.
PMID: 24832867
PMC: 4194277.
DOI: 10.1016/j.biopsych.2014.04.003.
Rapid changes in d1 and d2 dopamine receptor binding in striatal subregions after a single dose of phencyclidine.
Dalton V, Zavitsanou K
Clin Psychopharmacol Neurosci. 2013; 9(2):67-72.
PMID: 23429383
PMC: 3569081.
DOI: 10.9758/cpn.2011.9.2.67.
Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.
Sheffler D, Pinkerton A, Dahl R, Markou A, Cosford N
ACS Chem Neurosci. 2012; 2(8):382-93.
PMID: 22860167
PMC: 3369751.
DOI: 10.1021/cn200008d.
Deficits in emotional learning and memory in an animal model of schizophrenia.
Bolton M, Heaney C, Sabbagh J, Murtishaw A, Magcalas C, Kinney J
Behav Brain Res. 2012; 233(1):35-44.
PMID: 22569573
PMC: 3632713.
DOI: 10.1016/j.bbr.2012.04.049.
New insights on endocannabinoid transmission in psychomotor disorders.
Giuffrida A, Seillier A
Prog Neuropsychopharmacol Biol Psychiatry. 2012; 38(1):51-8.
PMID: 22521335
PMC: 3389227.
DOI: 10.1016/j.pnpbp.2012.04.002.
A case control association study and cognitive function analysis of neuropilin and tolloid-like 1 gene and schizophrenia in the Japanese population.
Banno M, Koide T, Aleksic B, Yamada K, Kikuchi T, Kohmura K
PLoS One. 2011; 6(12):e28929.
PMID: 22205981
PMC: 3243668.
DOI: 10.1371/journal.pone.0028929.
Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT(1A) Receptor-Dependent Mechanism.
Kargieman L, Riga M, Artigas F, Celada P
Neuropsychopharmacology. 2011; 37(3):723-33.
PMID: 22012474
PMC: 3260989.
DOI: 10.1038/npp.2011.249.
Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.
Boison D, Singer P, Shen H, Feldon J, Yee B
Neuropharmacology. 2011; 62(3):1527-43.
PMID: 21315743
PMC: 3119785.
DOI: 10.1016/j.neuropharm.2011.01.048.
Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.
DSouza M, Markou A
Neuropharmacology. 2011; 62(3):1564-73.
PMID: 21288470
PMC: 3116036.
DOI: 10.1016/j.neuropharm.2011.01.044.